Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Becton, Dickinson and Company

BDXNYSE
Healthcare
Medical - Instruments & Supplies
$184.23
$-1.16(-0.63%)
U.S. Market opens in 17h 20m

Becton, Dickinson and Company (BDX) Stock Forecast & Price Predictions

Get the latest Becton, Dickinson and Company (BDX) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$163.64
Change↓ $-20.59 (-11.18%)

Quarterly Forecast

Predicted Price$138.04
Change↓ $-46.19 (-25.07%)

Yearly Forecast

Predicted Price$159.94
Change↓ $-24.29 (-13.18%)

3 Years Forecast

Predicted Price$97.73
Change↓ $-86.50 (-46.95%)

5 Years Forecast

Predicted Price$35.36
Change↓ $-148.87 (-80.80%)

7 Years Forecast

Predicted Price$0.00
Change↓ $-184.23 (-100.00%)

Becton, Dickinson and Company Stock Forecast Summary

Becton, Dickinson and Company (BDX) stock is currently priced at $184.23. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $163.64.

In the long term, BDX shows a bearish trend. The 2027 forecast points to $159.94 (-13.18% change), while the 2031 forecast suggests $35.36 (-80.80% change). Looking 7 years ahead, projections estimate the stock could trade near $0.00, a -100.00% change from today’s price.

Overall Sentiment

Bearish

Short-Term Outlook

Bearish

Long-Term Outlook

Bearish

This mix indicates that Becton, Dickinson and Company stock is expected to face downside risk over the coming years.

Becton, Dickinson and Company yearly Price Forecast Chart

Explore the yearly forecast chart for BDX, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Becton, Dickinson and Company over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for BDXForecasting details for BDX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Becton, Dickinson and Company Stock Forecast 2026

The forecast for Becton, Dickinson and Company (BDX) in 2026 suggests a price of $159.94, representing a -13.18% move from today’s price.

Average Target: $159.94

Market Outlook: bearish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

Becton, Dickinson and Company Stock Forecast 2030

By 2030, Meyka AI projects BDX could trade near $35.36, showing a potential -80.80% compared to current levels.

Average Target: $35.36

Market Outlook: bearish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward Becton, Dickinson and Company.

Frequently Asked Questions